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In the February 2002 issue of the Journal, in the article
“Genomic Screening of Fibroblast Growth-Factor Re-
ceptor 2 Reveals a Wide Spectrum of Mutations in Pa-
tients with Syndromic Craniosynostosis,” by Kan et al.
(70:472–486), the following errors occurred: (1) on the
10th line in the left hand column on page 476, “mM”
should read “mM,” in both cases; and (2) in table 4, the
exon 15 polymorphism “1673-47GrA” should be
“1673-49GrA,” and “1673-10CrT” should be “1673-
12CrT.” The authors regret these errors.
In the July 2002 issue of the Journal, in the article
“Chronic Infantile Neurological Cutaneous and Artic-
ular Syndrome Is Caused by Mutations inCIAS1, a Gene
Highly Expressed in Polymorphonuclear Cells and
Chondrocytes,” by Feldmann et al. (71:198–203), in ta-
ble 1, the amino acid change in the second row (family
2) should be Q306K. The authors regret this error.
In the October 2002 issue, the Journal published a letter
entitled “Increased Rate of Twins among Affected Sib
Pairs,” by Peter Visscher (71:995–996), and a response
to this letter by Hodge et al. (71:996). The Hodge et al.
response discussed, among other things, an error in a
formula in Dr. Visscher’s letter. This error was corrected
in Dr. Visscher’s letter before publication, but, because
of an oversight by the Journal, Hodge et al. were not
given an opportunity to alter their response accordingly.
The Journal regrets this error.
Table 4
Mutations in RPGR-ORF15 in Affected Hemizygotes with XLRP
Mutationa Protein Changeb
No. of Patients
Affected
Deletion:
432delG Glu144fsTer230 1
483-4delGA Glu161fsTer182 9
481-4delGAGA Arg160fsTer229 1
499-502delAGGA Lys166fsTer229 1
503-6delGGGA Gly168fsTer231 1
570-1delAG Arg190fsTer248 1
631delA Glu210fsTer229 1
652-3delAG Glu217fsTer248 7
673-4delAG Glu224fsTer248 2
689-92delAGAG Glu230fsTer233 3
1184-5delGG Glu395fsTer493 1
1244-5delGG Glu415fsTer493 1
1339-40delAG Glu446fsTer493 1
Insertion:
185ins, 5bp Ala61fsTer111 1
352-460dup 1
Nonsense:
369GrT Glu123Ter 1
393GrT Glu131Ter 1
423GrA Glu141Ter 3
507GrT Glu169Ter 3
a Nucleotide positions and nomenclature are based on the work
of Vervoort et al. (2000).
b Frameshift mutations are designated according to the following
example: Glu144fsTer230 refers to a frameshift mutation in which
Glu144 is the first amino acid altered, with termination of the ORF
at residue 230.
In the June 2002 issue of the Journal, in the article “A
Comprehensive Mutation Analysis of RP2 and RPGR
in a North American Cohort of Families with X-Linked
Retinitis Pigmentosa,” by Breuer et al. (70:1545–1554),
the authors have identified errors in the numbering of
RPGR-ORF15 mutations, in table 4, that were due to
the use of prepublication sequence from Vervoort and
colleagues (Vervoort R, Lennon A, Bird AC, Tulloch B,
Axton R, Miano MG, Meindl A, Meitinger T, Ciccod-
icola A, Wright AF [2000] Mutational hot spot within
a new RPGR exon in X-linked retinitis pigmentosa. Nat
Genet 25:462–466). These errors have now been iden-
tified and corrected, and a revised version of table 4 is
presented below. (We thank Dr. Dror Sharon for bring-
ing this to our attention.) The authors regret the errors.
